On April 30, 2024, Intellective Biologics (Suzhou) Co., Ltd. officially entered into a strategic cooperation agreement worth nearly 2 billion RMB with Agricultural Bank, Bank of China, and Shanghai Pudong Development Bank for the commercial base project. This partnership empowers Intellective Biologics to construct the largest nationwide 192,000-liter bioproduct base project.
This bank-enterprise collaboration not only provides long-term financial security for Intellective Biologics but also signifies the establishment of deep strategic partnerships between Intellective Biologics and Agricultural Bank, Bank of China, and Shanghai Pudong Development Bank.
Chairman and CEO of Intellective Biologics, Li Zhi, stated: "We are very grateful for the trust and support from Agricultural Bank, Bank of China, and Shanghai Pudong Development Bank in our project. This cooperation will greatly help us improve production efficiency and accelerate digital transformation. In the future, Intellective Biologics will continue to increase investment in technological research and development in the biopharmaceutical field, contributing China's new quality productivity to the global health industry."
